The estimated Net Worth of George A Joulwan is at least $3.48 Million dollars as of 11 August 2020. George Joulwan owns over 6,000 units of Emergent Biosolutions Inc stock worth over $202,656 and over the last 21 years he sold EBS stock worth over $2,937,118. In addition, he makes $344,000 as Independent Director at Emergent Biosolutions Inc.
George has made over 20 trades of the Emergent Biosolutions Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently he sold 6,000 units of EBS stock worth $744,660 on 11 August 2020.
The largest trade he's ever made was exercising 14,251 units of Emergent Biosolutions Inc stock on 7 November 2017 worth over $255,093. On average, George trades about 1,151 units every 67 days since 2003. As of 11 August 2020 he still owns at least 26,771 units of Emergent Biosolutions Inc stock.
You can see the complete history of George Joulwan stock trades at the bottom of the page.
Gen.(Ret.) George A. Joulwan serves as Independent Director of the Company. Gen. Joulwan's distinguished military career spans 36 years from 1961 to his retirement as a four-star general and the Supreme Allied Commander of NATO in 1997. In 1998 General Joulwan founded, and currently serves as president of, One Team, Inc., which provides business consulting services. Previously, General Joulwan served as a director of General Dynamics Corporation from 1998 through 2012, and currently serves on several private company and charitable boards. He was a professor at the United States Military Academy at West Point and served on the Board of Trustees for the United States Military Academy. General Joulwan was a professor of National Security Strategy at the National Defense University. General Joulwan is a graduate of West Point and holds a Master's degree in Political Science and an Honorary Doctor of Law degree from Loyola University in Chicago. As a retired U.S. Army general, we believe General Joulwan brings a unique perspective to our board. Through his extensive and distinguished military career, he has developed critical leadership and management skills that we believe make him a significant contributor to our board. In addition, we believe General Joulwan's foreign policy experience and knowledge of the government and the military provide valuable insight into international defense markets and the global defense industry.
As the Independent Director of Emergent Biosolutions Inc, the total compensation of George Joulwan at Emergent Biosolutions Inc is $344,000. There are 15 executives at Emergent Biosolutions Inc getting paid more, with Robert Kramer having the highest compensation of $3,693,820.
George Joulwan is 80, he's been the Independent Director of Emergent Biosolutions Inc since 2013. There are 1 older and 20 younger executives at Emergent Biosolutions Inc. The oldest executive at Emergent Biosolutions Inc is Louis Sullivan, 86, who is the Independent Director.
George's mailing address filed with the SEC is 400 PROFESSIONAL DR, SUITE 400, , GAITHERSBURG, MD, 20879.
Over the last 18 years, insiders at Emergent Biosolutions Inc have traded over $131,382,266 worth of Emergent Biosolutions Inc stock and bought 4,647 units worth $138,981 . The most active insiders traders include Seamus Mulligan, Fuad El Hibri und Shahzad Malik. On average, Emergent Biosolutions Inc executives and independent directors trade stock every 21 days with the average trade being worth of $147,206. The most recent stock trade was executed by Kathryn C Zoon on 4 June 2024, trading 10,000 units of EBS stock currently worth $61,100.
emergent biosolutions is a global life sciences company dedicated to one simple mission—to protect and enhance life. we develop, manufacture, and deliver a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. through our work, we envision protecting and enhancing 50 million lives with our products by 2025. additional information about the company may be found at www.emergentbiosolutions.com. follow us @emergentbiosolu and @life_at_emergent
Emergent Biosolutions Inc executives and other stock owners filed with the SEC include: